Yi‐Long Wu

机构：Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University · ORCID：0000-0001-8734-2131

发表论文 9 篇 · 总被引 129 次 · h-index 4

代表论文

• HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced EGFR -mutated NSCLC after a third-generation EGFR TKI (2023 · Future Oncology · 被引 61)
• Radiomics-Based Support Vector Machine Distinguishes Molecular Events Driving the Progression of Lung Adenocarcinoma (2024 · Journal of Thoracic Oncology · 被引 32)
• Clinical recommendations for perioperative immunotherapy‐induced adverse events in patients with non‐small cell lung cancer (2021 · Thoracic Cancer · 被引 15)
• Molecular residual disease: A new clue for individualized approach in non‐small cell lung cancer (2023 · Medicine Advances · 被引 13)
• Neoadjuvant Immunochemotherapy in Resectable NSCLC With SMARCA4 Alterations (2025 · Journal of Thoracic Oncology · 被引 4)
• Quantifying Early-Stage Lung Adenocarcinoma Progression with a Radiomic Trajectory (2025 · npj Digital Medicine · 被引 3)